A
Amanda H Corbett
Researcher at University of North Carolina at Chapel Hill
Publications - 35
Citations - 1148
Amanda H Corbett is an academic researcher from University of North Carolina at Chapel Hill. The author has contributed to research in topics: Population & Efavirenz. The author has an hindex of 17, co-authored 35 publications receiving 1022 citations.
Papers
More filters
Journal ArticleDOI
Simultaneous determination of 17 antiretroviral drugs in human plasma for quantitative analysis with liquid chromatography-tandem mass spectrometry.
Byung Hwa Jung,Byung Hwa Jung,Naser L. Rezk,Arlene S. Bridges,Amanda H Corbett,Angela D. M. Kashuba +5 more
TL;DR: This work describes a sensitive method for the simultaneous determination of 17 antiretroviral drugs including nucleoside analog reverse transcriptase inhibitors, non-nucleoside analogous reverse transcript enzyme inhibitors, protease inhibitors and a nucleotide analogreverse transcriptase inhibitor in 50 microL of human plasma.
Journal ArticleDOI
Antiretroviral drug exposure in the female genital tract: implications for oral pre- and post-exposure prophylaxis.
Julie B. Dumond,Rosa F. Yeh,Kristine B. Patterson,Amanda H Corbett,Byung Hwa Jung,Naser L. Rezk,Arlene S. Bridges,Paul W. Stewart,Myron S. Cohen,Angela D. M. Kashuba +9 more
TL;DR: The findings support the use of lamivudine, zidovudines, tenofovir and emtricitabine as excellent pre-exposure/post-ex exposure prophylaxis (PrEP/PEP) candidates.
Journal Article
Common Herbal Dietary Supplement—Drug Interactions
TL;DR: Because most patients do not disclose supplement use to clinicians, the most important strategy for detecting herb-drug interactions is to develop a trusting relationship that encourages patients to discuss their dietary supplement use.
Journal ArticleDOI
Kaletra (Lopinavir/Ritonavir)
TL;DR: Lopinavir/ritonavir is an effective option for the treatment of HIV-1-infected individuals when used in combination with other antiretroviral agents and toxicity, drug interactions, and medication adherence are important considerations surrounding its clinical use.
Journal ArticleDOI
2017 HIVMA of IDSA Clinical Practice Guideline for the Management of Chronic Pain in Patients Living With HIV.
R. Douglas Bruce,Jessica S. Merlin,Paula J. Lum,Ebtesam Ahmed,Carla Alexander,Amanda H Corbett,Kathleen M. Foley,Kate Leonard,Glenn J. Treisman,Peter A. Selwyn +9 more
TL;DR: The types of chronic pain commonly seen among persons living with HIV (PLWH) are reviewed and the limited evidence base for treatment of chronic noncancer pain in this population is reviewed.